AMENDMENT NO. 1 TO REVENUE PARTICIPATION RIGHT PURCHASE AGREEMENTRevenue Participation Right Purchase Agreement • August 9th, 2024 • Cytokinetics Inc • Pharmaceutical preparations • New York
Contract Type FiledAugust 9th, 2024 Company Industry JurisdictionThis Amendment No. 1 To Revenue Participation Right Purchase Agreement, dated as of May 22, 2024 (this “Amendment”), is made and entered into by and between Cytokinetics, Incorporated, a Delaware corporation (the “Seller”), and Royalty Pharma Investments 2019 ICAV, an Irish collective asset-management vehicle (the “Buyer”).